These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37971454)

  • 21. Diagnostic efficacy of diffusion-weighted imaging and semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging in salivary gland tumors.
    Gökçe E; Beyhan M
    World J Radiol; 2023 Jan; 15(1):20-31. PubMed ID: 36721673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discrimination between benign and malignant lung lesions using volumetric quantitative dynamic contrast-enhanced MRI.
    Wei F; Weidong F; Wenming Z; Lei H; Xiaosan C; Zhongliang M; Qianyun L; Huashan L
    Curr Med Imaging; 2023 Jul; ():. PubMed ID: 37497704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved performance in differentiating benign from malignant sinonasal tumors using diffusion-weighted combined with dynamic contrast-enhanced magnetic resonance imaging.
    Wang XY; Yan F; Hao H; Wu JX; Chen QH; Xian JF
    Chin Med J (Engl); 2015 Mar; 128(5):586-92. PubMed ID: 25698188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults.
    Oh E; Yoon YC; Kim JH; Kim K
    Clin Radiol; 2017 Jul; 72(7):552-559. PubMed ID: 28325514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic contrast-enhanced and diffusion-weighted MR imaging in the characterisation of small, non-palpable solid testicular tumours.
    Manganaro L; Saldari M; Pozza C; Vinci V; Gianfrilli D; Greco E; Franco G; Sergi ME; Scialpi M; Catalano C; Isidori AM
    Eur Radiol; 2018 Feb; 28(2):554-564. PubMed ID: 28856410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of magnetic resonance imaging including dynamic contrast-enhanced magnetic resonance imaging in differentiation between inverted papilloma and malignant tumors in the nasal cavity.
    Wang X; Zhang Z; Chen X; Li J; Xian J
    Chin Med J (Engl); 2014; 127(9):1696-701. PubMed ID: 24791877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Signal intensity-time curve and quantitative dynamic contrast-enhanced magnetic resonance imaging in differentiating neoplasms of uterus].
    Guo Y; Jiang X; Liu G; Huang Y; Xu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 40(12):1357-64. PubMed ID: 26739079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors.
    Li HM; Feng F; Qiang JW; Zhang GF; Zhao SH; Ma FH; Li YA; Gu WY
    Abdom Radiol (NY); 2018 Nov; 43(11):3132-3141. PubMed ID: 29556691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic Contrast-Enhanced MR Perfusion in Differentiation of Benign and Malignant Brain Lesions.
    Cetinkaya E; Aralasmak A; Atasoy B; Tokdemir S; Toprak H; Toprak A; Kurtcan S; Alkan A
    Curr Med Imaging; 2022; 18(10):1099-1105. PubMed ID: 35331119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Feasibility study of dynamic contrast enhanced magnetic resonance imaging qualitative diagnosis of musculoskeletal tumors].
    Zhang J; Zuo PL; Cheng KB; Yu AH; Cheng XG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 48(2):287-91. PubMed ID: 27080283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
    Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
    BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
    Guo W; Zhang Y; Luo D; Yuan H
    Br J Radiol; 2020 Nov; 93(1115):20200751. PubMed ID: 32915647
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnostic Performance of Dynamic Contrast-Enhanced MRI and
    Zhang Y; Zhao H; Liu Y; Zeng M; Zhang J; Hao D
    Acad Radiol; 2022 Dec; 29(12):1842-1851. PubMed ID: 35396157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinguishing T1-2 and T3a tumors of rectal cancer with texture analysis and functional MRI parameters.
    Sun D; Wu X; Wang L; Li G; Huang J; Li Y
    Diagn Interv Radiol; 2022 May; 28(3):200-207. PubMed ID: 35748201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Assessment of Prostate Cancer Aggressiveness Using a Combination of Quantitative Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Zhu G; Luo J; Ouyang Z; Cheng Z; Deng Y; Guan Y; Du G; Zhao F
    Cancer Manag Res; 2021; 13():5287-5295. PubMed ID: 34239327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of multimodal magnetic resonance imaging in breast cancer and its correlation with pathological features and prognosis.
    Luo Q; Yang L; Zhou X
    Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8397-8403. PubMed ID: 37782156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The value of DISCO and MUSE-DWI combined with prostate specific antigen density in the diagnosis and risk stratification of prostate cancer].
    Chen ZQ; Zhang D; Wang Z; Song N; Ma AL; Zhang SR; Cai L
    Zhonghua Yi Xue Za Zhi; 2023 May; 103(19):1461-1468. PubMed ID: 37198108
    [No Abstract]   [Full Text] [Related]  

  • 39. Dependence of DCE-MRI biomarker values on analysis algorithm.
    Ng CS; Wei W; Bankson JA; Ravoori MK; Han L; Brammer DW; Klumpp S; Waterton JC; Jackson EF
    PLoS One; 2015; 10(7):e0130168. PubMed ID: 26208254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
    Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
    J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.